Business Daily Media

Men's Weekly

.

Application for clinical trial of AIM Vaccine’s human diploid rabies vaccine

An iterative process is highly effective in increasing the value of large items

HONG KONG SAR - Media OutReach Newswire - 8 November 2024 - AIM Vaccine (06660.HK), the world's second largest supplier of rabies vaccines, announced on 7th November that the application for clinical trial of the iterative-process highly-effective human diploid rabies vaccine developed by the Company has been submitted to the Center for Drug Evaluation (CDE) of National Medical Products Administration of China recently.


According to the announcement, the i iterative-process highly-effective human diploid rabies vaccine developed by AIM Vaccine shows an iterative upgrade compared to the traditional human diploid rabies vaccines of the first generation in many aspects.

The iterative-process highly-effective human diploid rabies vaccine developed by the Company has taken the lead in breaking through the technical bottlenecks of low virus titer and low yield in the traditional process. It has been optimized and innovated in the purification process with the product quality and safety significantly improved.

Compared with the number of traditional rabies vaccinations, this product developed by the Group can be vaccinated with either "five-needle approach", "simple four-needle approach" or "2-1-1 four-needle approach", which is more flexible and convenient.

There are two kinds of rabies vaccines, namely the serum-containing rabies vaccine and the serum-free rabies vaccine. However, no serum-free rabies vaccine has been registered or marketed yet. The mainstream Vero cell rabies vaccine and human diploid rabies vaccine currently available in the market are serum-containing rabies vaccines.

Compared with the traditional Vero cell rabies vaccines, human diploid rabies vaccine uses human diploid cells instead of Vero cells, which are homologous to humans and have a natural safety advantage. The human diploid rabies vaccine currently available in the market is 3 to 5 times more expensive than the Vero cell rabies vaccine, with higher product added value.

According to the announcement, AIM Vaccine has completed the construction of an iterative-process high-efficiency human diploid rabies vaccine workshop that meets international standards, and has completed the production of commercial-scale Phase III clinical trial samples, which is capable of producing this product in large scale.

China is the world's largest rabies vaccine market. According to the 2024 interim performance report of AIM Vaccine, the approved lot release volume of China's rabies vaccines increased from 58.80 million in 2019 to 78.50 million in 2021, representing an increase of 33.6%. It is expected that the market scale will increase to RMB22.0 billion by 2030, partially due to the iteration of rabies vaccine products upgrade. With the expansion of the pet market and the popularization of pre-exposure immunity knowledge, it is expected that the demand for human rabies vaccines will continue to grow in the future.
Hashtag: #AIM

The issuer is solely responsible for the content of this announcement.

News from Asia

Apical Joins Industry Leaders to Launch Aceh Sustainable Palm Oil Working Group

SINGAPORE - Media OutReach Newswire - 25 September 2025 - Apical joins leading industry players and Yayasan Inisiatif Dagang Hijau (YIDH), the local foundation established by IDH – The Sustainable...

Siam Paragon Bangkok Watch Week 2025 Opens with a Historic Celebration

Founders and top executives from the world’s leading luxury watch brands united for an unprecedented evening celebrating horological culture, the largest luxury watch event in Southeast Asia. BANG...

Huawei Releases the ISP/MSP Business Success Driven by RAMS White Paper

SHANGHAI, CHINA - Media OutReach Newswire - 25 September 2025 - During HUAWEI CONNECT 2025, Huawei released the ISP/MSP Business Success Driven by RAMS White Paper at the summit themed "Powering ...

VinFast and MUFG Bank partner up over a $100 million Green Loan facility

SINGAPORE - Media OutReach Newswire - 25 September 2025 - VinFast has secured a USD 100 million Green Loan facility from MUFG Bank, Ltd., to be used for VinFast's development and international ex...

COCOSPACE to Host First Soundproofing Consultation & Experience Event in Singapore

Japan’s Leading Soundproofing Items Make Their Debut in Singapore SINGAPORE - Media OutReach Newswire - 24 September 2025 - Pialiving Co., Ltd. (Headquarters: Fukuoka, Japan; CEO: Fusako Muromizu)...

Tenchijin's "KnoWaterleak" and AISIN's "Michi-log" Announcing Collaboration on Japan's First Pilot Project for Integrated Road and Water Infrastructure Management in Iwata City

Collaboration between Satellite Data and In-Vehicle AI, Looking Toward Global Expansion SHIZUOKA, JAPAN - Media OutReach Newswire - 25 September 2025 - Tenchijin Inc., a space-tech innovator revol...

AS Watson Celebrates World Pharmacists Day

Honouring Over 3,000 Pharmacists and Nearly 10,000 Health Professionals Worldwide HONG KONG SAR - Media OutReach Newswire - 25 September 2025 - On World Pharmacists Day, AS Watson proudly celebra...

#AyamBersamaMu: Ayam Brand™ and Sunway XFarms Join Forces to Empower Children with Nutrition and Real-World Learning

The collaboration combines hands-on learning for children with nationwide food aid distribution to over 1,000 underprivileged individuals. KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 25 Sep...

Yuno Accelerates Global Growth with APAC Expansion Across China and Singapore

With Singapore as its regional headquarters in APAC and new operations in China, the payments orchestrator is simplifying cross-border commerce for global merchants.

Huawei Releases Global Digitalization and Intelligence Index Report for the Power Industry to Boost Electric Power Intelligence

SHANGHAI, CHINA - Media OutReach Newswire - 25 September 2025 - At the Huawei Global Electric Power Summit held during HUAWEI CONNECT 2025, Huawei released the Global Digitalization and Intellige...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...

Why it’s time telcos rethink location and put customer experience first

Maurice Zicman, Vice President - CX Strategy at TP in Australia unpacks why the telco industry must rethink old assumptions and focus on digital-f...

Manny Shah: Is your business disappearing from Google? You’re not alone

Small business owners across Australia are panicking as their websites vanish from Google’s front pages overnight. According to Manny Shah, cofounde...

Sell by LayBy